Makers of fetanyl & synthetic thc donated $500,000 in AZ prohibition campaign
Here Are the Prohibitionists Who've Donated $10,000 or More to Keep Marijuana a Felony in Arizona
$100,000-plus donors:
Discount Tire $1 million
Arizona Chamber of Commerce $918,000
Sheldon Adelson (Nevada casino magnate) $500,000
Insys Therapeutics Inc. (maker of Fentanyl and synthetic THC) $500,000
Empire Southwest LLC (construction-equipment company) $350,000
Services Group of America (food distribution company has a division that sells food to private prisons) $180,000
SAM Action (national anti-marijuana group) $165,000
T. Denny Sanford (South Dakota businessman) $100,000
Larry Van Tuyl (auto dealership mogul who owns a $125-million-dollar yacht) $100,000
Randy Kendrick (wife of Ken Kendrick, Arizona Diamondbacks owner) $100,000
$50,000-plus donors:
Arizona Mining Association $51,000
Arizona Automobile Dealers Association $50,000
Michael Ahearn (co-founder of First Solar) $50,000
http://www.phoenixnewtimes.com/news/here-are-the-prohibitionists-whove-donated-10-000-or-more-to-keep-marijuana-a-felony-in-arizona-8794628
Anti-marijuana campaign's biggest donor? Chandler pharma company
A Chandler pharmaceutical company made a $500,000 donation to the campaign opposing the legalization of marijuana for recreational use, making it the largest funder of the effort to defeat Proposition 205.
INSYS Therapeutics Inc. makes a fast-acting form of fentanyl that is sprayed under the tongue, and "may provide pain relief in as little as 5 minutes," according to its website. INSYS also touts on its website a "capability to develop pharmaceutical cannabinoids," the active components of the marijuana plant.
In a statement, Insys Therapeutics said it opposes Prop. 205 "because it fails to protect the safety of Arizonas citizens, and particularly its children."
"...We believe that all available medicines should meet the clinical standards set by the FDA. Insys firmly believes in the potential clinical benefits of cannabinoids. Like many in the healthcare community, we hope that patients will have the opportunity to benefit from these potential products once clinical trials demonstrate their safe and effective use. To that end, we are currently conducting research with leading universities and institutions to ensure the clinical benefits of cannabinoids for unmet medical needs including epilepsy, anxiety and PTSD," Insys' said in its statement.
http://www.azcentral.com/story/news/politics/elections/2016/09/08/anti-marijuana-campaigns-biggest-donor-chandler-pharma-company/89981456/